Evidence map›Paper›PMID 28261680›Full record

ArticleInvestigative and clinical urology2017

Long-term adherence to antimuscarinic drugs when treating overactive bladder in the older: Subjective reason and objective factors.

Kirill Vladimirovich Kosilov, Sergay Alexandrovich Loparev, Irina Gennadyevna Kuzina, Boris Izrailevich Geltser, Olga Viktorovna Shakirova, Natalya Sergeevna Zhuravskaya, Alexandra Lobodenko

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Investigative and clinical urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kirill Vladimirovich KosilovDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.; Department of Theory and Methods of Adaptive Physical Education, Far Eastern Federal University, Vladivostok, Russian Federation.
Sergay Alexandrovich LoparevDepartment of Urology, City Polyclinic No. 3, Vladivostok, Russian Federation.
Irina Gennadyevna KuzinaDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.
Boris Izrailevich GeltserDepartment of Social Sciences, School of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.
Olga Viktorovna ShakirovaDepartment of Theory and Methods of Adaptive Physical Education, Far Eastern Federal University, Vladivostok, Russian Federation.
Natalya Sergeevna ZhuravskayaDepartment of Theory and Methods of Adaptive Physical Education, Far Eastern Federal University, Vladivostok, Russian Federation.
Alexandra LobodenkoUndergrad of the Institute of Humanities, Far Eastern Federal University, Vladivostok, Russian Federation.
Far Eastern Federal University · RUSt. Petersburg State Medical Academy "City Polyclinic №44" · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeComparison of subjective reasons for the refusal of antimuscarinic treatment and the state of objective economic, social, psychological and health status markers in the elderly with overactive bladder. MATERIALS AND

methodsOne thousand seven hundred thirty-six (1,736) patients participated in the experiment: 1,036 or 59.7% of women, and 700 or 40.3% of men aged over 60 years (average age, 68.1 years) who took antimuscarinic (AM) drugs during the year. The control of objective parameters was carried out by studying patients' medical records, the use of overactive bladder questionnaire short form and Medical Outcomes Study 36-item Shor-Form Health Survey, voiding diaries, uroflowmetry, as well as income certificates from the Tax Inspectorate, support documentation for expenses on drugs.

resultsFifty-two point six percent (52.6%) of patients preserved adherence to treatment during the first 6 months, 30.1% - during the follow-up period. The average time of reaching a 30-day break in the AM drugs administration was 174 days. In 36.5% of cases of the refusal of treatment, patients referred to medical reasons for the refusal, in 31.6% of cases disturbance was established in objective health status markers (differences were significant in 30% of the follow-up time). The percentage of refusals of treatment for social and psychological reasons (13.2%) was significantly lower (p≤0.05), than the percentage of individuals with statuses altered objectively (21.9%).

conclusionsA significant share of elderly patients taking AM drugs when treating overactive bladder is inclined to overestimate the importance of health factors influencing their decisions and to underestimate the importance of social and psychological factors, and an urologist should take it into account for the efficacy evaluation.

Indexed as

Drug MonitoringAgedAged, 80 and overDrug Administration ScheduleFemaleFrail ElderlyHealth SurveysHumansMaleMiddle AgedMuscarinic AntagonistsPatient Acceptance of Health CareProspective StudiesQuality of LifeRussiaSocioeconomic FactorsMuscarinic AntagonistsComplianceFrail elderlyMuscarinic antagonistsOveractive urinary bladder

Identifiers

PMID28261680
PMCPMC5330372
OpenAlexW2590086943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.